Source data. by Shihao Zhou (5774795)

“…Under wide-field imaging in primary somatosensory and visual cortices in mice with high labeling density (80–90%), SomaFRCaMPi exhibits up to 40% higher SNR and decreased artifactual correlation across neurons. Altogether, SomaFRCaMPi improves the accuracy and scale of neuronal activity imaging at single-neuron resolution in densely labeled brain tissues due to a 2–3-fold enhanced automated neuronal segmentation, 50% higher fraction of responsive cells, up to 2-fold higher SNR compared to jRGECO1a. …”

Behavior effects after LABP acute exposure. by Kassia Martins Fernandes Pereira (12219197)

“…Asterisks indicate statistical differences between groups (*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001). n = 24/group a-20 min; 28/group b-20 min; 28/group c-25 min; 50/group d-60 min.…”

DDX5 and DDX17 are required for KSHV lytic reactivation in BCBL1 cells and primary infection in endothelial cells. by Praneet Kaur Sandhu (21156149)

TLR3 deficiency promoted the activation of TGF-β1/Smad2/3 pathway and myofibroblast caused by <i>C</i>. by Yuru Wang (846969)

Impaired bone formation in <i>Col1a1-Krm2</i> transgenic mice. by Jochen Schulze (365258)

“…<p>(A) Toluidine blue staining of non-decalcified vertebral body sections from 6 weeks old female wildtype and <i>Col1a1-Krm2</i> transgenic littermates revealing that the normal appearance of cuboidal osteoblasts (arrows) covering trabecular bone surfaces is only observed in wildtype controls (scale bars, 50 µm). …”

Long-term health status and trajectories of seriously injured patients: A population-based longitudinal study by Belinda J. Gabbe (193450)

“…The 3-level EuroQol 5 dimensions questionnaire (EQ-5D-3L) was collected, and mixed-effects regression modelling was used to identify predictors of outcome, and recovery trajectories, for the EQ-5D-3L items and summary score. Mean (SD) age of participants was 50.8 (21.6) years, and 72% were male. …”

Barbie audit data. by Cylie Williams (3446018)

“…</p><p>Main outcome measures</p><p>Over time there was a decreased prevalence in equinus foot posture from 100% in the first time period to 40% in the last. …”

The FEET system of barbie categorisation. by Cylie Williams (3446018)

“…</p><p>Main outcome measures</p><p>Over time there was a decreased prevalence in equinus foot posture from 100% in the first time period to 40% in the last. …”

S1 Graphical abstract - by Lefei Yu (12274846)

“…<div><p>A number of studies demonstrate the therapeutic effectiveness of <i>Radix Bupleuri</i> (RB) and <i>Hedysarum Multijugum Maxim</i> (HMM) in treating liver fibrosis, but the exact molecular mechanisms remain unclear. …”

The top 10 hub targets. by Lefei Yu (12274846)

“…<div><p>A number of studies demonstrate the therapeutic effectiveness of <i>Radix Bupleuri</i> (RB) and <i>Hedysarum Multijugum Maxim</i> (HMM) in treating liver fibrosis, but the exact molecular mechanisms remain unclear. …”

Original images for blots and gels requirements. by Lefei Yu (12274846)

“…<div><p>A number of studies demonstrate the therapeutic effectiveness of <i>Radix Bupleuri</i> (RB) and <i>Hedysarum Multijugum Maxim</i> (HMM) in treating liver fibrosis, but the exact molecular mechanisms remain unclear. …”

The top 10 active ingredients. by Lefei Yu (12274846)

“…<div><p>A number of studies demonstrate the therapeutic effectiveness of <i>Radix Bupleuri</i> (RB) and <i>Hedysarum Multijugum Maxim</i> (HMM) in treating liver fibrosis, but the exact molecular mechanisms remain unclear. …”

PEG10-derived VLPs are naturally released by human cells. by Will Campodonico (20485651)

The flow chart. by Lefei Yu (12274846)

“…<div><p>A number of studies demonstrate the therapeutic effectiveness of <i>Radix Bupleuri</i> (RB) and <i>Hedysarum Multijugum Maxim</i> (HMM) in treating liver fibrosis, but the exact molecular mechanisms remain unclear. …”

The active ingredients in RB-HMM. by Lefei Yu (12274846)

“…<div><p>A number of studies demonstrate the therapeutic effectiveness of <i>Radix Bupleuri</i> (RB) and <i>Hedysarum Multijugum Maxim</i> (HMM) in treating liver fibrosis, but the exact molecular mechanisms remain unclear. …”

Physiologic values. by Hiroki Iwata (2434012)

“…The serum syndecan-1 concentration, a glycocalyx component, in the 4% hydrogen group (5.7 ± 4.4 pg/mL) was lower than in the control (19.5 ± 6.6 pg/mL) and 2% hydrogen (19.8 ± 5.0 pg/mL) groups (<i>P</i> < 0.001 for each), but it was not significantly different from the sham group (6.2 ± 4.0 pg/mL, <i>P</i> = 0.999). …”

Brg1 inhibition reduces KSHV lytic reactivation. by Praneet Kaur Sandhu (21156149)

Poly (I:C) intervention presented significantly beneficial on the liver lesion, liver inflammation and biliary injury caused by <i>C</i>. by Yuru Wang (846969)

Adjuvant Iodine-125 Brachytherapy for Hepatocellular Carcinoma after Complete Hepatectomy: A Randomized Controlled Trial by Kaiyun Chen (364164)

“…The follow-up ended in January 2010, and lasted for 7.7–106.4 months with a median of 47.6 months. TTR was significantly longer in the ¹²⁵I group (mean of 60.0 months vs. 36.7 months in the control). …”

TLR3 deficiency exacerbated liver inflammation and biliary damage caused by <i>C</i>. by Yuru Wang (846969)